Log in
ETR:AFX

Carl Zeiss Meditec AG (AFX.F) Stock Forecast, Price & News

€121.90
-1.10 (-0.89 %)
(As of 10/20/2020 12:00 AM ET)
Add
Compare
Today's Range
€121.90
Now: €121.90
€123.60
50-Day Range
€92.85
MA: €105.20
€122.40
52-Week Range
€67.70
Now: €121.90
€122.40
Volume123,446 shs
Average Volume94,405 shs
Market Capitalization$10.90 billion
P/E Ratio91.31
Dividend Yield0.55%
BetaN/A
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery. This segment also offers optical coherence tomography devices, perimeters, fundus cameras, slit lamps, and therapeutic and refractive lasers for the diagnosis and treatment of various eye diseases, such as refraction, glaucoma, and other retinal diseases, as well as FORUM, an eye care data management system. The Microsurgery segment provides surgical microscopes and visualization solutions for neuro, spinal, dental, and plastic and reconstructive surgeries, as well as for ear, nose, and throat surgery; products for surgical treatment of tumors or vascular diseases, such as aneurysms; and INTRABEAM, a intraoperative radiotherapy device. Carl Zeiss Meditec AG serves ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The company was founded in 2002 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
Read More
Carl Zeiss Meditec AG (AFX.F) logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.1Community Rank: 2.3Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.04 out of 5 stars

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-3641-2200
Employees3,230

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.40 billion
Cash Flow€0.32 per share
Book Value€16.29 per share

Profitability

Miscellaneous

Market Cap$10.90 billion
Next Earnings Date12/11/2020 (Estimated)
OptionableNot Optionable
€121.90
-1.10 (-0.89 %)
(As of 10/20/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AFX News and Ratings via Email

Sign-up to receive the latest news and ratings for AFX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Carl Zeiss Meditec AG (AFX.F) (ETR:AFX) Frequently Asked Questions

How has Carl Zeiss Meditec AG (AFX.F)'s stock been impacted by Coronavirus (COVID-19)?

Carl Zeiss Meditec AG (AFX.F)'s stock was trading at €84.30 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AFX stock has increased by 44.6% and is now trading at €121.90.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Carl Zeiss Meditec AG (AFX.F)?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Carl Zeiss Meditec AG (AFX.F) in the last year. There are currently 3 sell ratings, 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Carl Zeiss Meditec AG (AFX.F)
.

When is Carl Zeiss Meditec AG (AFX.F)'s next earnings date?

Carl Zeiss Meditec AG (AFX.F) is scheduled to release its next quarterly earnings announcement on Friday, December 11th 2020.
View our earnings forecast for Carl Zeiss Meditec AG (AFX.F)
.

What price target have analysts set for AFX?

9 brokerages have issued 1-year price targets for Carl Zeiss Meditec AG (AFX.F)'s shares. Their forecasts range from €76.00 to €120.00. On average, they expect Carl Zeiss Meditec AG (AFX.F)'s share price to reach €99.63 in the next twelve months. This suggests that the stock has a possible downside of 18.3%.
View analysts' price targets for Carl Zeiss Meditec AG (AFX.F)
.

Who are some of Carl Zeiss Meditec AG (AFX.F)'s key competitors?

What other stocks do shareholders of Carl Zeiss Meditec AG (AFX.F) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Carl Zeiss Meditec AG (AFX.F) investors own include Covestro AG (1COV.F) (1COV), AbbVie (ABBV), AmerisourceBergen (ABC), Allianz (ALV), Daimler (DAI), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM) and SAP (SAP).

Who are Carl Zeiss Meditec AG (AFX.F)'s key executives?

Carl Zeiss Meditec AG (AFX.F)'s management team includes the following people:
  • Dr. Ludwin Monz, Pres, CEO & Chairman of Management Board (Age 57, Pay $1.23M)
  • Mr. Justus Felix Wehmer, CFO & Member of the Management Board (Age 55, Pay $497.9k)
  • Mr. Jan Willem de Cler, Head of Surgical Ophthalmology & Member of Management Board
  • Mr. Sebastian Frericks, Director of Investor Relations
  • Mr. Martin Wiechmann, Head of the Planetarium Bus. Unit

What is Carl Zeiss Meditec AG (AFX.F)'s stock symbol?

Carl Zeiss Meditec AG (AFX.F) trades on the ETR under the ticker symbol "AFX."

What is Carl Zeiss Meditec AG (AFX.F)'s stock price today?

One share of AFX stock can currently be purchased for approximately €121.90.

How big of a company is Carl Zeiss Meditec AG (AFX.F)?

Carl Zeiss Meditec AG (AFX.F) has a market capitalization of $10.90 billion and generates $1.40 billion in revenue each year. Carl Zeiss Meditec AG (AFX.F) employs 3,230 workers across the globe.

What is Carl Zeiss Meditec AG (AFX.F)'s official website?

The official website for Carl Zeiss Meditec AG (AFX.F) is www.zeiss.com.

How can I contact Carl Zeiss Meditec AG (AFX.F)?

Carl Zeiss Meditec AG (AFX.F)'s mailing address is Goeschwitzer Strasse 51-52, JENA, 07745, Germany. The company can be reached via phone at +49-3641-2200.

This page was last updated on 10/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.